Simon Renders

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, DKFZ-ZMBH Alliance, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Deutsches Konsortium für Translationale Krebsforschung · ORCID：0000-0001-7883-2956

发表论文 139 篇 · 总被引 3027 次 · h-index 21

代表论文

• Differentiation, ageing and leukaemia alter the metabolic profile of human bone marrow haematopoietic stem and progenitor cells (2025 · Nature Cell Biology · 被引 20)
• Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML (2026 · Cell stem cell · 被引 4)
• A FABulous Couple: Adding PHENotype to GENotype Improves HMA/VEN Response Prediction in AML (2025 · Blood Cancer Discovery · 被引 2)
• Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment (2026 · Cancer Cell · 被引 1)
• Prospective clinical validation of MAC-scoring as an affordable, real-time biomarker for HMA/venetoclax response in AML (2025 · Blood · 被引 1)
• IDH3 regulates citrate homeostasis to control metabolic fitness and venetoclax resistance of AML stem cells (2026 · Blood)